Conditions · Alzheimer's disease & early-stage dementia
Alzheimer's disease & early-stage dementia — frontier options in Texas
Prefer to look first? Browse the live map without signing up.
30 open options
- TRIALPHASE1 / PHASE2RECRUITING
Interleukine-2 (IL-2) Plus Semaglutide in Alzheimer's Disease
IL-2 (Aldesleukin) · Semaglutide Plus IL-2 · Placebo — 1 site
- TRIALPHASE3RECRUITING
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
Donanemab · Placebo — 59 sites
- TRIALPHASE1 / PHASE2RECRUITING
Snacks and Brain Health
Pecan snack · Pretzel snack — 1 site
- TRIALPHASE2RECRUITING
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
BMS-986368 · Placebo — 78 sites
- TRIALPHASE1RECRUITING
ACT for Individuals With MNCD and Their Care Partners
Acceptance Commitment Therapy — 1 site
- TRIALPHASE3RECRUITING
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
KarXT · KarX-EC — 252 sites
- TRIALNARECRUITING
Enhancing Attention in Elderly Using a Brain-Computer-Interface
transcranial electrical stimulation · Mindfulness Meditation — 2 sites
- TRIALPHASE3RECRUITING
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
No Intervention — 229 sites
- TRIALPHASE2RECRUITING
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
ML-007C-MA · Placebo — 55 sites
- TRIALPHASE2RECRUITING
Pathways Relating Amnestic MCI to a Mild Traumatic Brain Injury History
High Definition Transcranial Direct Current Stimulation — 1 site
- TRIALNARECRUITING
ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's Disease
Blood Brain Barrier (BBB) Disruption — 10 sites
- TRIALNARECRUITING
Smartphone-based Cognitive Emotion Regulation Training for Unpaid Primary Caregivers of Persons With Alzheimer's Disease
Cognitive Emotion Regulation Training via Psychological Distancing · Cognitive Emotion Regulation Training via Reinterpretation — 1 site
- TRIALPHASE3RECRUITING
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
KarXT — 431 sites
- TRIALNARECRUITING
Novel Brain Stimulation Treatment for Neuropsychiatric Symptoms in Alzheimer's Disease
Brain Stimulation — 1 site
- TRIALPHASE2RECRUITING
Clinical Trial on Agitation in Alzheimer's Dementia
IGC-AD1-Active · IGC-AD1-Placebo — 31 sites
- TRIALPHASE3RECRUITING
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
KarXT · KarX-EC · Placebo — 127 sites
- TRIALNARECRUITING
Closed-Loop Brain Stimulation as a Potential Intervention for Cognitive Decline
Closed-loop TBS · Open-loop TBS — 1 site
- TRIALPHASE3ENROLLING_BY_INVITATION
ACP-204 in Adults With Alzheimer's Disease Psychosis Open Label Extension Study
ACP-204 — 76 sites
- TRIALPHASE2RECRUITING
A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease
SAR448851 · Placebo — 11 sites
- TRIALPHASE1 / PHASE2RECRUITING
A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)
Placebo (Study Part 1a) · ACI-24.060 at Dose A in Study Part 1a · ACI-24.060 at Dose B in Study Part 1a — 26 sites
- TRIALPHASE3RECRUITING
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
KarXT · KarX-EC · Placebo — 119 sites
- TRIALPHASE3RECRUITING
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
Xanomeline/Trospium Chloride Capsule · Xanomeline Enteric Capsule · Placebo — 162 sites
- TRIALNARECRUITING
Remotely-supervised Neuromodulation in PPA
Lexical Retrieval Cascade Treatment · Remotely Supervised Transcranial Direct Current Stimulation- Active · Remotely Supervised Transcranial Direct Current Stimulation - Sham — 2 sites
- TRIALNARECRUITING
Advancing Alzheimer's Care: Home-based tDCS for Affective Symptoms
Transcranial direct current stimulation (tDCS) · Sham tDCS — 1 site
- TRIALNARECRUITING
IHT for Mild Cognitive Impairment
IHT Treatment · Sham-IHT Control — 1 site
- TRIALPHASE2 / PHASE3RECRUITING
A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
Remternetug (SC) · Matching Placebo (Remternetug) — 37 sites
- TRIALNARECRUITING
Cognitive Reserve and Response to Speech-Language Intervention in Bilingual Speakers With Primary Progressive Aphasia
Video-Implemented Script Training for Aphasia (VISTA) · Lexical Retrieval Training (LRT) — 3 sites
- TRIALNARECRUITING
Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase
LOCK Sleep Program · No intervention (control period/baseline data collection) — 3 sites
- TRIALNANOT_YET_RECRUITING
Jigsawdio Multisensory Platform for People With Mild Cognitive Impairment, Alzheimer's Disease, or Related Dementias
Jigsawdio Multisensory Puzzle Platform · Standard Jigsaw Puzzle Activity — 2 sites
- TRIALEARLY_PHASE1RECRUITING
Educational Support Group Program for Bilingual and Spanish-speaking Carepartners and People With Progressive Aphasia
Psychosocial educational, support group and implementation of strategies — 1 site
Live from ClinicalTrials.gov, refreshed at most hourly · registry query ↗
Not medical advice. Trial0 is a navigation service, not a medical provider. Nothing here is medical advice or a recommendation to pursue any treatment; eligibility matching is informational, based on published registry criteria, and only the trial site or treating clinician can determine actual eligibility. Decisions belong with the patient and their own doctors.